Skip to main content
Median Diagnostics Inc. logo

Median Diagnostics Inc. — Investor Relations & Filings

Ticker · 233250 ISIN · KR7233250000 KO Manufacturing
Open in API
Filings indexed 118 across all filing types
Latest filing 2024-03-12 Audit Report / Informat…
Country KR South Korea
Listing KO 233250

About Median Diagnostics Inc.

https://www.mediandiagnostics.com/en

Median Diagnostics Inc. specializes in the development, manufacturing, and supply of in-vitro diagnostic products for animal diseases. The company provides a comprehensive portfolio of diagnostic solutions, including ELISA and PCR kits, rapid tests, and standard reagents. It also produces essential raw materials such as monoclonal antibodies and antigens. A primary focus is on offering 'Total Diagnostic Systems' for high-consequence animal diseases, including African Swine Fever (ASF), Foot-and-Mouth Disease (FMD), High Pathogenicity Avian Influenza (HPAI), Porcine Epidemic Diarrhea (PED), and Bovine Viral Diarrhea (BVD). The company also supplies raw materials for human disease diagnostic applications.

Recent filings

Filing Released Lang Actions
사업보고서 (2023.12)
Audit Report / Information Classification · 100% confidence The document is a formal 'Independent Auditor's Report' (독립된 감사인의 감사보고서) for Median Diagnostics (주식회사 메디안디노스틱) for the fiscal year ending December 31, 2023. It includes the auditor's opinion, management's responsibilities, and the full set of consolidated financial statements (Statement of Financial Position, Statement of Comprehensive Income, Statement of Changes in Equity, Statement of Cash Flows, and Notes). This is a standalone audit report and financial statement package, which fits the 'Audit Report / Information' category. FY 2023
2024-03-12 Korean
주주총회소집공고
AGM Information Classification · 98% confidence The document is a 'Notice of General Meeting of Shareholders' (주주총회소집공고) for Median Diagnostics. It contains the meeting agenda, including the approval of financial statements, appointment of auditors, and remuneration limits for directors and auditors. It also includes 'Management Reference Materials' (경영참고사항) which provide business overviews and financial context for the shareholders. This document is a standard proxy statement/information circular sent to shareholders to solicit their votes for the upcoming Annual General Meeting. In the context of the provided categories, this aligns with Proxy Solicitation & Information Statement (PSI).
2024-03-05 Korean
주주총회소집결의
AGM Information Classification · 98% confidence The document is a formal notice of a General Meeting of Shareholders (주주총회소집 결의) issued by Median Diagnostics. It outlines the date, location, and agenda items (financial statement approval, auditor appointment, and remuneration limits) for the upcoming meeting. This type of document is a standard proxy solicitation/information statement provided to shareholders to inform them of meeting details and agenda items.
2024-02-23 Korean
주주명부폐쇄기간또는기준일설정
Regulatory Filings Classification · 95% confidence The document is a short regulatory notice regarding the closure of the shareholder register for the purpose of determining voting rights for an upcoming Annual General Meeting. It does not contain the full meeting materials or proxy statements, but rather serves as a formal regulatory announcement of the record date and register closure period. Given it is a standard regulatory notification that does not fit into specific categories like AGM-R or PSI, it is classified as a general regulatory filing.
2023-12-12 Korean
기업설명회(IR)개최결과
Regulatory Filings Classification · 100% confidence The document is a short notification (under 1,000 characters) announcing the results of an Investor Relations (IR) meeting held by Median Diagnostics. It provides the date, time, location, and attendees of the meeting, and explicitly mentions that the IR materials are posted on the Korea Exchange's disclosure system. Per the 'Menu vs Meal' rule, since this is a brief announcement of an event/report rather than the full presentation itself, it is classified as a Report Publication Announcement (RPA).
2023-11-09 Korean
기업설명회(IR)개최
Report Publication Announcement Classification · 100% confidence The document is a formal announcement regarding the scheduling and logistics of an upcoming Investor Relations (IR) presentation. It specifies the date, time, location (online), target audience, and purpose of the meeting. Since it is an announcement of an event rather than the presentation slides themselves, and it does not fit into specific categories like 'Call Transcript' or 'Annual Report', it is classified as a Regulatory Filing (RNS) as it serves as a standard corporate disclosure notice.
2023-10-24 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.